海外の治験の状況「1」での検索結果
26278件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- Type 2 Diabetes Mellitus
- Taiwan
- 2011-11-14
Not recruiting
- The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
- Type 2 Diabetes
- Denmark
- 2011-10-19
Not Recruiting
- Does the GLP-1 like-hormone (Victoza®) improve the glycemic control to physical training in patients with type 2 diabetes?
- Diabetes type 2 MedDRA version: 14.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
- Denmark
- 2011-08-26
Not recruiting
- The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1
- Pharmacogenetics of Metformin
- Denmark
- 2011-07-21
Not recruiting
- Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
- Diabetes
- Denmark
- 2011-06-14
Not Recruiting
- The GLP-1 receptor agonist liraglutide can slow down the progression of Alzheimer’s disease
- Alzheimer's disease MedDRA version: 14.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Denmark
- 2011-06-01
Not recruiting
- Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
- Hypoglycaemia
- Denmark
- 2011-05-02
Not recruiting
- Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Israel
- 2011-02-24
Not recruiting
- Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY
- Taste Disorder, Primary, Sweet
- Switzerland
- 2011-02-22
Not Recruiting
- A randomized open study to compare the efficacy and safety of GLP-1 analogue (Liraglutide) versus DPP-4 inhibitor (Vildagliptin) in patients with Type 2 Diabetes.
- Type 2 diabetes
- Japan
- 2011-02-01
Not recruiting
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
- Low Grade Glioma;Glioblastoma Multiforme;Anaplastic Astrocytoma;Anaplastic Oligodendroglioma;Oligoastrocytoma
- United States
- 2011-01-21
Not recruiting
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- Diabetes Mellitus;Diabetes Mellitus, Type 2;Obesity
- Netherlands
- 2011-01-20
Not Recruiting
- Effect of glucagon like peptide -1 analogues of obese type 2 diabetic patients with abdominal fat
- Obesity, diabetes
- China
- 2016-03-25
Not Recruiting
- Comparative study between serum galectin 1 level in azospermic and oligoathenozoospermic patients
- male infertility
- Africa
- 2016-02-24
Not recruiting
- Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
- Coronary Angiography;Glucagon-like Peptide-1;Coronary Angiography;Glucagon-like Peptide-1;Coronary Angiography;Glucagon-like Peptide-1;Coronary Angiography;Glucagon-like Peptide-1
- 2017-04-23
Not recruiting
- Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients
- Diastolic Dysfunction;Hypertension;Inflammation;Diastolic Dysfunction;Hypertension;Inflammation;Diastolic Dysfunction;Hypertension;Inflammation;Diastolic Dysfunction;Hypertension;Inflammation
- 2017-04-16
Not Recruiting
- Investigation of the effect of InterLeukin-1 receptor Antagonist on markers of inflammation in non-ST elevation acute coronary syndromes
- Non-ST elevation acute coronary syndromes Circulatory System Coronary syndromes
- United Kingdom
- 2006-10-03
Not recruiting
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
- Malignant Melanoma
- Switzerland
- 2006-03-23
Not recruiting
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
- Malignant Melanoma
- Switzerland
- 2006-03-23
Not recruiting
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
- Melanoma
- Germany
- 2006-03-23